PCV103 - The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales

Howard H.Z. Thom; W Hollingworth; P A Bryden; J Sterne; P N Bodalia; P Davies; J A Lopez-Lopez; G N Okoli; D M Caldwell; S Dias; D Eaton; J Higgins; C Salisbury; Jelena Savovic; R Sofat; A Stephens-Boal; A Hingorani; N J Welton

doi:10.1016/j.jval.2015.09.872

PCV103 - The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales

Howard H.Z. Thom, W Hollingworth, P A Bryden, J Sterne, P N Bodalia, P Davies, J A Lopez-Lopez, G N Okoli, D M Caldwell, S Dias, D Eaton, J Higgins, C Salisbury, Jelena Savovic, R Sofat, A Stephens-Boal, A Hingorani, N J Welton

Centre for Reviews and Dissemination

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	Undefined/Unknown
Pages (from-to)	A391-A392
Journal	Value in Health
Volume	18
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2015.09.872
Publication status	Published - Nov 2015

Keywords

Journal Article

Access to Document

10.1016/j.jval.2015.09.872

Cite this

Thom, H. H. Z., Hollingworth, W., Bryden, P. A., Sterne, J., Bodalia, P. N., Davies, P., Lopez-Lopez, J. A., Okoli, G. N., Caldwell, D. M., Dias, S., Eaton, D., Higgins, J., Salisbury, C., Savovic, J., Sofat, R., Stephens-Boal, A., Hingorani, A., & Welton, N. J. (2015). PCV103 - The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales. Value in Health, 18(7), A391-A392. https://doi.org/10.1016/j.jval.2015.09.872

@article{b47a4fc0bbb0421d937d7ca22dc72cf6,

title = "PCV103 - The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales",

keywords = "Journal Article",

author = "Thom, {Howard H.Z.} and W Hollingworth and Bryden, {P A} and J Sterne and Bodalia, {P N} and P Davies and Lopez-Lopez, {J A} and Okoli, {G N} and Caldwell, {D M} and S Dias and D Eaton and J Higgins and C Salisbury and Jelena Savovic and R Sofat and A Stephens-Boal and A Hingorani and Welton, {N J}",

year = "2015",

month = nov,

doi = "10.1016/j.jval.2015.09.872",

language = "Undefined/Unknown",

volume = "18",

pages = "A391--A392",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "7",

}

Thom, HHZ, Hollingworth, W, Bryden, PA, Sterne, J, Bodalia, PN, Davies, P, Lopez-Lopez, JA, Okoli, GN, Caldwell, DM, Dias, S, Eaton, D, Higgins, J, Salisbury, C, Savovic, J, Sofat, R, Stephens-Boal, A, Hingorani, A & Welton, NJ 2015, 'PCV103 - The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales', Value in Health, vol. 18, no. 7, pp. A391-A392. https://doi.org/10.1016/j.jval.2015.09.872

TY - JOUR

T1 - PCV103 - The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales

AU - Thom, Howard H.Z.

AU - Hollingworth, W

AU - Bryden, P A

AU - Sterne, J

AU - Bodalia, P N

AU - Davies, P

AU - Lopez-Lopez, J A

AU - Okoli, G N

AU - Caldwell, D M

AU - Dias, S

AU - Eaton, D

AU - Higgins, J

AU - Salisbury, C

AU - Savovic, Jelena

AU - Sofat, R

AU - Stephens-Boal, A

AU - Hingorani, A

AU - Welton, N J

PY - 2015/11

Y1 - 2015/11

KW - Journal Article

U2 - 10.1016/j.jval.2015.09.872

DO - 10.1016/j.jval.2015.09.872

M3 - Meeting abstract

SN - 1098-3015

VL - 18

SP - A391-A392

JO - Value in Health

JF - Value in Health

IS - 7

ER -